ArticleThe Journal of infectious diseases2013
Determining HIV incidence in populations: moving in the right direction.
Article in The Journal of infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.Scientific reports · 2017Pooled it
- HIV-phyloTSI: subtype-independent estimation of time since HIV-1 infection for cross-sectional measures of population incidence using deep sequence data.BMC bioinformatics · 2025Article
- A top scoring pairs classifier for recent HIV infections.Statistics in medicine · 2021Article
- Cross-sectional HIV incidence estimation in an evolving epidemic.Statistics in medicine · 2019Article
- Cross-Sectional HIV Incidence Estimation with Missing Biomarkers.Statistical communications in infectious diseases · 2018Article
- Development of a Multiplex Assay for Concurrent Diagnoses and Detection of HIV-1, HIV-2, and Recent HIV-1 Infection in a Single Test.AIDS research and human retroviruses · 2018Article
- HIITE: HIV-1 incidence and infection time estimator.Bioinformatics (Oxford, England) · 2018Article
- Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.Journal of the International AIDS Society · 2018Article
- Assays for estimating HIV incidence: updated global market assessment and estimated economic value.Journal of the International AIDS Society · 2017Article
- Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece.Epidemiology and infection · 2017Article
- Article
- Strengthening HIV surveillance: measurements to track the epidemic in real time.African journal of AIDS research : AJAR · 2016Article
- Article
- Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.PloS one · 2015Article
- Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.AIDS research and human retroviruses · 2014Article
- Developing high-throughput HIV incidence assay with pyrosequencing platform.Journal of virology · 2014Article
- Cross-sectional HIV incidence estimation in HIV prevention research.Journal of acquired immune deficiency syndromes (1999) · 2013Article
- Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.PloS one · 2013Article
- Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.PloS one · 2013Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
23129757What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.